What is the current stock price of Elixxer Ltd. (ELIXF)?

As of the latest market data, Elixxer Ltd. (ELIXF) is trading at $0.03. The stock has seen a loss of 0.00% today.

Does Elixxer Ltd. (ELIXF) pay a dividend?

Based on current data, Elixxer Ltd. does not have a confirmed active dividend policy.

What is the market cap of Elixxer Ltd.?

The current market capitalization of Elixxer Ltd. (ELIXF) is approximately unavailable.

ELIXF

Elixxer Ltd.·Healthcare

0.03

0.000%(+0.00)

Market Closed

0.04

21.343%(+0.01)

After Hours

Last Updated: — ET

52W L: $0.0052W H: $0.10

ELIXF NEWS

newsfilecorp.com

Feb 2

Elixxer Provides Update on Secured and Unsecured Loans

Toronto, Ontario--(Newsfile Corp. - February 2, 2026) - Elixxer Ltd. (TSXV: ELXR.H) ("Elixxer" or the "Company") announces that, further to its press release of July 4, 2025, the Company has entered into an amending agreement dated January 29, 2026 (the "Amending Agreement") with an effective date of January 1, 2026, with AIP Asset Management Inc. (the "Security Agent") and AIP Convertible Private Debt Fund L.P.

newsfilecorp.com

Jan 14

Elixxer Announces Completion of Debt Settlement

Toronto, Ontario--(Newsfile Corp. - January 14, 2026) - Elixxer Ltd. (TSXV: ELXR.H) ("Elixxer" or the "Company") is pleased to announce that, further to its press release of September 5, 2025, September 16, 2025 and November 6, 2025, it has settled an aggregate of $6,923,742.46 through the issuance of an aggregate of 83,924,151 common shares (each, a "Common Share") at a deemed issuance price of $0.0825 per Common Share (the "Debt Settlement").

Company Profile

Elixxer Ltd. operates as a cannabis investment firm in Canada, Australia, Italy, Jamaica, and Switzerland. It invests in cannabis-related businesses, which are fully licensed for cultivation, production, and/or sale of medical and specialty cannabis and cannabis-derived products in the pharmaceutical sector. The company was formerly known as LGC Capital Ltd. and changed its name to Elixxer Ltd. in August 2019. Elixxer Ltd. was incorporated in 2004 and is based in Montreal, Canada.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2017-12-14

Beta

-0.54

Websitewww.elixxer.com↗